“In a typical study you have thousands of people working on the protocol, how do you ensure that they all understand the nuances and details?"
John Silowsky, Clinical Trial Lead
.png)
“myClin has developed a cloud-based tool to simplify communication and task management between trial sponsor, lead investigator, site manager and service providers in between.”
MedCity News
"myClin makes it simple to centralize and disseminate essential information across our clinical study team."
Vice President, Clinical Operations
Trevena
The expectations of regulatory inspectors are rising over time - requirements are getting tighter and sponsors are expected to make better use of their systems and data. Our speaker has very relevant experience from hosting an FDA inspection (2019) where this reality was clearly illustrated.
Learn how to include local site reality in how you design your study. In this session you will get the chance to hear from experienced site coordinators about what sites really think of your study processes. This will include how to keep you study moving during the COVID-19 pandemic.
So, Clinical Operations when you can't actually visit your sites! As if running international GCP trials wasn't complex enough suddenly we can't visit sites like we are used to.
Read this paper from our Use Case Series to understand how myClin can not only streamline the communication with clinical sites, but also dramatically increase engagement and compliance.
myClin, the leading Clinical Trial Knowledge Platform, allows for sponsors to connect more closely with investigators and other investigative site staff in a collaborative, secure, and efficient manner.
As a single and secure collaboration channel, the myClin platform can streamline and accelerate protocol development while keeping all parties in sync. On myClin, reviews occur in parallel with everybody seeing contributions from other team members.
This paper provides a modern definition of oversight and what it involves, and illustrates how the myClin platform builds a strong oversight directly within your study team communication and collaboration channels.
Regulatory scrutiny in clinical research has intensified in recent years, and there are no signs that the intensity of the regulatory environment is abating.
The expectations of regulatory inspectors are rising over time - requirements are getting tighter and sponsors are expected to make better use of their systems and data. Our speaker has very relevant experience from hosting an FDA inspection (2019) where this reality was clearly illustrated.
.png)
.png)
.png)